-->

Innovative therapeutics

Investors

SEC Filings

NASDAQBMRN
FormDescriptionDateFormat
4Statement of changes in beneficial ownership of securitiesNov 9, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 7, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 7, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 7, 2012View HTMLDownload DOCDownload PDF
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsNov 5, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesNov 5, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesNov 1, 2012View HTMLDownload DOCDownload PDF
10-QQuarterly report which provides a continuing view of a company's financial positionOct 29, 2012View HTMLDownload DOCDownload PDFDownload XLSView XBRLDownload XBRL
8-KReport of unscheduled material events or corporate eventOct 25, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesOct 24, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 24, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 23, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 18, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 16, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 3, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesOct 1, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 26, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 17, 2012View HTMLDownload DOCDownload PDF
CT ORDERConfidential treatment orderSep 14, 2012View HTMLDownload DOCDownload PDF
3Initial filing by director officer or owner of more than ten percent.Sep 14, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 12, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesSep 6, 2012View HTMLDownload DOCDownload PDF
8-KReport of unscheduled material events or corporate eventSep 5, 2012View HTMLDownload DOCDownload PDFDownload XLS
4Statement of changes in beneficial ownership of securitiesAug 24, 2012View HTMLDownload DOCDownload PDF
4Statement of changes in beneficial ownership of securitiesAug 6, 2012View HTMLDownload DOCDownload PDF
1-25      26-50      51-75      76-100      101-125      126-150      151-154

BioMarin

Diseases

Lysosomal Storage Disorders (MPS I, MPS IVA, MPS VI, CLN2 disease) PKU, LEMS

Products

Palynziq™
Brineura™
Vimizim®
Kuvan®
Naglazyme®
Aldurazyme®
Firdapse®

Patient/Physician Support Contact Information

BioMarin RareConnections
Tel: 866.906.6100
Fax: 888.863.3361
E-mail: support@biomarin-rareconnections.com

Global Medical Information

Contact Global Medical Information